Wellinks, which bills itself as a digital healthcare company, has announced that it will partner with Careabout Health…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
Lower respiratory diseases including chronic obstructive pulmonary disease (COPD)Â were the sixth leading cause of death in the U.S. in…
The voice of people with chronic obstructive pulmonary disease (COPD) becomes more pitched and sounds breathy or hoarse at…
One in six adults in the U.S. with chronic obstructive pulmonary disease (COPD) didn’t adhere to their medications due…
Permanent night shift work is associated with a nearly 50% higher risk of developing chronic obstructive pulmonary disease (COPD)…
A Phase 3 clinical trial assessing the potential of triple-combination Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) to improve cardiopulmonary outcomes in people with…
Remote monitoring reduced hospitalization rates and emergency room visits for patients with chronic obstructive pulmonary disease (COPD), a recent…
Biofourmis and Beacon Health System have partnered for an in-home monitoring program specifically meant for patients with complex…
Signify Health, a U.S. healthcare platform, has added spirometry testing for chronic obstructive lung disease (COPD) to…
AeroRx Therapeutics is teaming up with HCmed Innovations to develop a new therapeutic combination of different classes of bronchodilators —…